Divi's Laboratories Limited — Others, 04-02-2025: Shareholders meeting

Divi's Laboratories has announced a board meeting to seek shareholder approval for the re-appointment of Dr. Kiran S. Divi as Whole-time Director and CEO for a further five-year term starting April 1, 2025. The company has engaged Kfin Technologies to facilitate the remote e-voting process, which will take place from February 5 to March 6, 2025. Dr. Divi, who has been with the company since 2001, plays a crucial role in overseeing operations and strategic initiatives. Approval of this resolution is expected to bolster investor confidence, reflecting stability in leadership and ongoing commitment to strategic objectives.